Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

ABSTRACT: This paper presents an advanced mathematical framework for modeling combat dynamics between two opposing forces using nonlinear reaction-diffusion equations. Extending classical Lanchester ...

Will mortgage rates go higher if the government takes the GSEs out of conservatorship? Many people would say yes if there were no government backing of these two giants, but on Tuesday evening the ...

Happy Birthday, Java! Even as rivals Python and Rust claim the spotlight, proponents say the 30-year-old language will continue to forge ahead. Introduced by Sun Microsystems on May 23, 1995, Java is ...

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ: RXRX). The company has emerged as a ...

The market is viewing NVIDIA's decision to keep its 7.7 million share stake in Recursion while divesting from other AI holdings as a significant strategic move. This decision indicates NVIDIA's ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.